Huron Consulting Group Inc.
NASDAQ•HURN
CEO: Mr. C. Mark Hussey C.F.A., C.M.A., CPA, M.B.A.
Sector: Industrials
Industry: Consulting Services
Listing Date: 2004-10-13
Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment provides digital solutions, spanning technology, and analytic-related services; Huron Research product suite, a software suite designed to facilitate and enhance research administration service delivery and compliance; research-focused consulting and managed services; strategy and operations consulting services for public and private colleges and universities, research institutes, and other education-related organizations. The Commercial segment delivers digital services and software products, and financial advisory services to financial, energy and utilities, professional and business services, life science, consumer products, and industrials and manufacturing industries, as well as public sector and nonprofit organizations. The company was incorporated in 2002 and is headquartered in Chicago, Illinois.
Contact Information
550 West Van Buren Street, Chicago, IL, 60607, United States
312-583-8700
Market Cap
$2.24B
P/E (TTM)
21.4
28.9
Dividend Yield
--
52W High
$186.78
52W Low
$116.12
52W Range
Rank29Top 17.8%
5.2
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.2 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025
Financial Dashboard
Q4 2025 Data
Revenue
$441.96M+0.00%
4-Quarter Trend
EPS
$1.77+0.00%
4-Quarter Trend
FCF
$123.83M+0.00%
4-Quarter Trend
2025 Annual Earnings Highlights
Key Highlights
Revenue Growth Across Segments Revenues before reimbursable expenses increased 11.9% to $1.66B in 2025, driven by Consulting/Managed Services strength across all segments.
Adjusted EBITDA Margin Rises Adjusted EBITDA margin rose to 14.3% in 2025, up from 13.5% last year, showing operational leverage gains despite net income dip.
Capital Returned to Shareholders Deployed $166.2M capital returning value to shareholders through common stock repurchases during 2025, with $99.0M remaining authorization.
Healthcare Revenue Strength Healthcare segment revenues grew 10.7% to $837.5M before reimbursements, supported by strong consulting demand across providers.
Risk Factors
Talent Retention Competitive Risk Inability to hire and retain skilled professionals in competitive labor market risks increasing labor costs and negatively affecting margins.
Short-Term Client Contract Risk Short-term client contracts, often 12 months or less, create unpredictable operating results and revenue volume fluctuations year-to-year.
Investment Impairment Potential Convertible debt investment impairment risk exists due to external regulatory environment impacting investee cash flows and profitability, noted by $10.4M charge in 2025.
Managing Global Growth Challenges Managing organizational challenges associated with continued global growth risks impairing ability to maintain standards and execute strategy effectively.
Outlook
Strategy Focus on Digital Growth Growth strategy emphasizes accelerating Healthcare/Education expansion while rapidly growing global digital capability leveraging AI evolution across industries.
Commitment to Margin Expansion Committed to achieving operating income margin expansion by improving pricing realization and focusing on high-return business areas.
Financing Flexibility Maintained Internally generated liquidity plus $578.6M unused credit capacity supports long-term growth needs, acquisitions, and capital expenditures.
Continued Strategic Acquisitions Company plans to continue executing strategic, tuck-in acquisitions to bolster capabilities across key industry segments like Healthcare and Commercial.
Peer Comparison
Revenue (TTM)
$8.87B
$5.42B
$5.38B
Gross Margin (Latest Quarter)
48.0%
42.0%
39.7%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| FTAI | $23.59B | 47.1 | 257.0% | 78.9% |
| UNF | $4.80B | 32.6 | 6.5% | 2.8% |
| TEX | $3.76B | 17.0 | 11.2% | 45.8% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
3.8%
Moderate Growth
4Q Net Income CAGR
7.7%
Profitability Improving
Cash Flow Stability
75%
Volatile Cash Flow
Deep Research
Next earnings:Apr 27, 2026
EPS:-
|Revenue:-
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement | LTM |
|---|
No Data